Literature DB >> 14476374

Plasma free fatty acid in liver disease.

A MORTIAUX, A M DAWSON.   

Abstract

The plasma free fatty acid level was raised in the majority of 131 patients with a variety of liver disorders, and included both those with severe liver cell damage and those with relatively good liver cell function and obstructive jaundice. This raised level is probably due to an increased mobilization of depot fat, for glucose, which inhibits peripheral liberation of free fatty acids, caused a fall in the plasma level and obliteration of the femoral venous-arterial difference in patients with liver disease comparable with that in normal persons. In addition, the plasma free fatty acid flux was measured using palmitate-1-C(14) and was found to be increased in patients with liver disease.

Entities:  

Keywords:  FATTY ACIDS/blood; LIVER DISEASES/blood

Mesh:

Substances:

Year:  1961        PMID: 14476374      PMCID: PMC1413354          DOI: 10.1136/gut.2.4.304

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  20 in total

1.  The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function.

Authors:  J CAESAR; S SHALDON; L CHIANDUSSI; L GUEVARA; S SHERLOCK
Journal:  Clin Sci       Date:  1961-08       Impact factor: 6.124

2.  The lipid composition of serum in patients with liver disease.

Authors:  G B PHILLIPS
Journal:  J Clin Invest       Date:  1960-11       Impact factor: 14.808

3.  Plasma unesterfiled fatty acid concentrations in neoplastic disease.

Authors:  P S MUELLER; D M WATKIN
Journal:  J Lab Clin Med       Date:  1961-01

4.  Effect of previous starvation on the response of plasma lipids and free fatty acids to a fat meal.

Authors:  M J ALBRINK; R S NEUWIRTH
Journal:  J Clin Invest       Date:  1960-03       Impact factor: 14.808

5.  Lipoprotein lipase response in Laennec's cirrhosis.

Authors:  S P BAKER; H LEVINE; L TURNER; A DUBIN
Journal:  Proc Soc Exp Biol Med       Date:  1958-12

6.  Acute effect of psychologic stimuli upon plasma non-esterified fatty acid level.

Authors:  M D BOGDONOFF; E H ESTES; D TROUT
Journal:  Proc Soc Exp Biol Med       Date:  1959-03

7.  Blood pyruvic-acid and alpha-ketoglutaric-acid levels in liver disease and hepatic coma.

Authors:  A M DAWSON; J DE GROOTE; W S ROSENTHAL; S SHERLOCK
Journal:  Lancet       Date:  1957-02-23       Impact factor: 79.321

8.  Blood pyruvic acid response to intravenous glucose or insulin in the normal and in patients with liver disease and with diabetes mellitus.

Authors:  D S AMATUZIO; N SHRIFTER; F L STUTZMAN; S NESBITT
Journal:  J Clin Invest       Date:  1952-08       Impact factor: 14.808

9.  Fasting concentrations of non-esterified fatty acids in diabetic and non-diabetic plasma and diurnal variations in normal subjects.

Authors:  C MUNKNER
Journal:  Scand J Clin Lab Invest       Date:  1959       Impact factor: 1.713

10.  The metabolism of albumin-bound C14-labeled unesterified fatty acids in normal human subjects.

Authors:  D S FREDRICKSON; R S GORDON
Journal:  J Clin Invest       Date:  1958-11       Impact factor: 14.808

View more
  14 in total

1.  High-Fat Diet Alters Serum Fatty Acid Profiles in Obesity Prone Rats: Implications for In Vitro Studies.

Authors:  Tzu-Wen Liu; Timothy D Heden; E Matthew Morris; Kevin L Fritsche; Victoria J Vieira-Potter; John P Thyfault
Journal:  Lipids       Date:  2015-08-29       Impact factor: 1.880

2.  Plasma alpha-lipoprotein pattern in acute viral hepatitis.

Authors:  N Thalassinos; J Hatzioannou; P Scliros; R Kanaghinis; C Anastasiou; P Crocos; D Thomopoulos; C Gardikas
Journal:  Am J Dig Dis       Date:  1975-02

3.  Relationships between tryptophan in serum and CSF, and 5-hydroxyindoleacetic acid in CSF of man: effect of cirrhosis of liver and probenecid administration.

Authors:  S N Young; S Lal; T L Sourkes; F Feldmuller; A Aronoff; J B Martin
Journal:  J Neurol Neurosurg Psychiatry       Date:  1975-04       Impact factor: 10.154

4.  Lipid metabolism in experimental cholestasis.

Authors:  C O Record; K G Alberti; D H Williamson
Journal:  Biochem J       Date:  1971-10       Impact factor: 3.857

5.  Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.

Authors:  D Berkowitz
Journal:  Am J Dig Dis       Date:  1969-10

6.  [Serum free fatty acids in the course of infectious hepatitis in children].

Authors:  U Spahn
Journal:  Klin Wochenschr       Date:  1967-05-15

7.  Serum metabolic signatures of primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Lauren N Bell; Jacob Wulff; Megan Comerford; Raj Vuppalanchi; Naga Chalasani
Journal:  Liver Int       Date:  2014-09-22       Impact factor: 5.828

8.  Individual free fatty acids in patients with liver disease.

Authors:  O Gunnlaugsson; D Berkowitz
Journal:  Am J Dig Dis       Date:  1977-11

9.  A study of carbohydrate metabolism in postnecrotic cirrhosis liver.

Authors:  R T Yeung; C C Wang
Journal:  Gut       Date:  1974-11       Impact factor: 23.059

10.  Cirrhosis and diabetes. I. Increased incidence of diabetes in patients with Laennec's cirrhosis.

Authors:  H O Conn; W Schreiber; S G Elkington; T R Johnson
Journal:  Am J Dig Dis       Date:  1969-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.